Cargando…

Comparison of onset time, duration of action, and intubating conditions after cisatracurium 0.15 mg/kg in young and elderly patients

INTRODUCTION: Tracheal intubation during anesthesia can be facilitated by the neuromuscular blocking agent cisatracurium. However, limited data exists about onset time, duration of action and effect on intubating conditions in elderly patients above 80 years of age. We hypothesized that elderly pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vested, Matias, Kristensen, Camilla Meno, Pape, Pernille, Vang, Malene, Hartoft, Mian, Hjelmdal, Caroline, Rasmussen, Lars Simon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639316/ https://www.ncbi.nlm.nih.gov/pubmed/36344924 http://dx.doi.org/10.1186/s12871-022-01881-5

Ejemplares similares

Rocuronium 0.3 or 0.9 mg/kg comparing onset time, duration of action, and intubating conditions in patients 80 years and older: A randomized study
por: Vested, Matias, et al.
Publicado: (2022)

Tracheal intubating conditions in elderly patients when train-of-four count is zero after rocuronium 0.6 or 0.9 mg/kg. A secondary analysis
por: Vested, Matias, et al.
Publicado: (2023)

The effect of low dose ketamine and priming of cisatracurium on the intubating condition and onset time of cisatracurium
por: Ahn, Byung-Ryang, et al.
Publicado: (2012)

Effects on Intubating Conditions of Pretreatment with Remifentanil before Administration of Cisatracurium
por: Jeong, Hye Jin, et al.
Publicado: (2012)

Minimum Alveolar Concentration of Sevoflurane with Cisatracurium for Endotracheal Intubation in Neonates
por: Zhang, Bin, et al.
Publicado: (2019)

A comparison of the clinical duration and recovery characteristics of cisatracurium after priming using rocuronium or cisatracurium: preliminary study
por: Jung, Ki Tae, et al.
Publicado: (2014)

The dose effect of ephedrine on the onset time and intubating conditions after cisatracurium administration
por: Cha, Dong Guk, et al.
Publicado: (2014)

Comparison of the Incidence of Sore Throat After Rapid Sequence Intubation With Succinylcholine and Cisatracurium
por: Solatpour, Farhad, et al.
Publicado: (2014)

Comparison of etomidate and propofol on intubating conditions and the onset time associated with cisatracurium administration
por: Ko, Young-Kwon, et al.
Publicado: (2015)

Anesthesiologist's satisfaction using between cisatracurium and rocuronium for the intubation in the anesthesia induced by remifentanil and propofol
por: Lee, Hyunjung, et al.
Publicado: (2013)

Comparison of Intubating Conditions at 60 Seconds with Cisatracurium 4*ED95 Dose and Cisatracurium 2*ED95 Dose Plus Priming Dose and Low Dose Ketamine
por: Daga, Rahul G., et al.
Publicado: (2023)

Effect of cisatracurium versus atracurium on intraocular pressure in patients undergoing tracheal intubation for general anesthesia
por: Jabalameli, Mitra, et al.
Publicado: (2011)

Evaluation of intubating conditions with rocuronium 0.6 mg/kg using train of four stimulation in elective surgery
por: Kumar, Nishant, et al.
Publicado: (2022)

Comparative analysis of efficacy of lignocaine 1.5 mg/kg and two different doses of dexmedetomidine (0.5 μg/kg and 1 μg/kg) in attenuating the hemodynamic pressure response to laryngoscopy and intubation
por: Gulabani, Michell, et al.
Publicado: (2015)

Comparison of the anesthetic effects between 5 mg/kg of alfaxalone and 10 mg/kg of propofol administered intravenously in cats
por: TAMURA, Jun, et al.
Publicado: (2021)

Comparison of the initial and residual speed of Ixodes scapularis kill on dogs treated with a single dose of Bravecto(®) Chew (25 mg/kg fluralaner) or Simparica TRIO(®) (1.2 mg/kg sarolaner, 24 µg/kg moxidectin, 5 mg/kg pyrantel)
por: Reif, Kathryn E., et al.
Publicado: (2023)

Effective doses of cisatracurium in the adult and the elderly
por: Kim, Jeong Ho, et al.
Publicado: (2016)

TI nulling and contrast conditions with a 0.15 mmol/kg dosage of MultiHance as compared to the standard 0.2 mmol/kg gadolinium dosage in patients with myocardial infarcts
por: Yamrozik, June A, et al.
Publicado: (2009)

The Real-Time and Patient-Specific Prediction for Duration and Recovery Profile of Cisatracurium Based on Deep Learning Models
por: Wang, Kan, et al.
Publicado: (2022)

Modified electroconvulsive therapy in a resource-challenged setting: Comparison of two doses (0.5 mg/kg and 1 mg/kg) of suxamethonium chloride
por: Aaron, Olurotimi I., et al.
Publicado: (2020)

Cisatracurium degradation: Intravenous fluid warmer the culprit?
por: Khan, Rashid M, et al.
Publicado: (2015)

Temperature and cisatracurium degradation: So what is new?
por: Sharma, Vandana, et al.
Publicado: (2015)

Effects of Combined Rocuronium and Cisatracurium in Laparoscopic Cholecystectomy
por: Park, Woo Young, et al.
Publicado: (2017)

Baricitinib/cisatracurium besilate: Rhabdomyolysis: case report
Publicado: (2021)

What is the easier and more reliable dose calculation for iv Phenytoin in children at risk of developing convulsive status epilepticus, 18 mg/kg or 20 mg/kg?
por: Prasad, Manish, et al.
Publicado: (2013)

Randomized Single-Blinded Non-inferiority Trial Of 7 mg/kg Pentamidine Isethionate Versus 4 mg/kg Pentamidine Isethionate for Cutaneous Leishmaniaisis in Suriname
por: Hu, Ricardo V. P. F., et al.
Publicado: (2015)

Breast lesion detection and characterization with contrast‐enhanced magnetic resonance imaging: Prospective randomized intraindividual comparison of gadoterate meglumine (0.15 mmol/kg) and gadobenate dimeglumine (0.075 mmol/kg) at 3T
por: Clauser, Paola, et al.
Publicado: (2018)

Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma
por: Ascierto, Paolo Antonio, et al.
Publicado: (2020)

Correction: Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma
Publicado: (2020)

Pharmacodynamics of cisatracurium in the intensive care unit: an observational study
por: Dieye, Eric, et al.
Publicado: (2014)

Effect of dexamethasone on the onset time and recovery profiles of cisatracurium
por: So, Keum Young, et al.
Publicado: (2017)

Continuously protracted infusion of cisatracurium besilate in patients with ARDS
por: Yuan, Ziming, et al.
Publicado: (2022)

Cisatracurium-besilate: ICU-acquired weakness: case report
Publicado: (2022)

Do Thyroid Disrupting Chemicals Influence Foetal Development during Pregnancy?
por: Hartoft-Nielsen, Marie-Louise, et al.
Publicado: (2011)

Neoadjuvant ipilimumab (3 mg/kg or 10 mg/kg) and high dose IFN-α2b in locally/regionally advanced melanoma: safety, efficacy and impact on T-cell repertoire
por: Tarhini, Ahmad, et al.
Publicado: (2018)

Comparing the frequency of isotretinoin-induced hair loss at <0.5-mg/kg/d versus ≥0.5-mg/kg/d dosing in acne patients: A systematic review
por: Lytvyn, Yuliya, et al.
Publicado: (2022)

Efficacy of radiotherapy in patients on progression after treatment with ipilimumab 3 mg/kg
por: Grimaldi, Antonio M, et al.
Publicado: (2014)

A Comparison of the Blood Glucose, Growth Hormone, and Cortisol Responses to Two Doses of Insulin (0.15 U/kg vs. 0.10 U/kg) in the Insulin Tolerance Test: A Single-Centre Audit of 174 Cases
por: Yeoh, Phillip, et al.
Publicado: (2022)

Selection of metric for indoor‐outdoor source apportionment of metals in PM(2.5): mg/kg versus ng/m(3)
por: Rasmussen, Pat E., et al.
Publicado: (2021)

A Multicentre Randomized Controlled Trial of the Efficacy and Safety of Single-Dose Praziquantel at 40 mg/kg vs. 60 mg/kg for Treating Intestinal Schistosomiasis in the Philippines, Mauritania, Tanzania and Brazil
por: Olliaro, Piero L., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_qgtgu0tui0p99hpma6e64s8nhs